Intelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher

Intelligent Bio Solutions Inc. (NASDAQ:INBS)’s stock price rose 4.5% during trading on Thursday . The stock traded as high as $3.28 and last traded at $2.80. Approximately 162,360 shares changed hands during trading, a decline of 94% from the average daily volume of 2,738,967 shares. The stock had previously closed at $2.68.

Intelligent Bio Solutions Price Performance

The business has a 50-day simple moving average of $4.32 and a two-hundred day simple moving average of $3.97. The stock has a market capitalization of $7.96 million, a price-to-earnings ratio of -0.03 and a beta of 4.82. The company has a quick ratio of 0.39, a current ratio of 0.57 and a debt-to-equity ratio of 0.07.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its earnings results on Friday, February 9th. The company reported ($2.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.24) by $1.17. The company had revenue of $0.76 million for the quarter. Intelligent Bio Solutions had a negative return on equity of 266.16% and a negative net margin of 544.63%. As a group, research analysts predict that Intelligent Bio Solutions Inc. will post -3.67 earnings per share for the current fiscal year.

Institutional Trading of Intelligent Bio Solutions

A hedge fund recently bought a new stake in Intelligent Bio Solutions stock. Citadel Advisors LLC bought a new position in shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 156,390 shares of the company’s stock, valued at approximately $53,000. Citadel Advisors LLC owned approximately 21.48% of Intelligent Bio Solutions as of its most recent SEC filing. 32.97% of the stock is currently owned by hedge funds and other institutional investors.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.